Swedish Company Looks to London for Top Level Research
(LONDON, Ontario) – Top level executives representing SensoDetect met today with Mayor Fontana to discuss how London could be part of future plans and opportunities for the Swedish based company.
This meeting followed on the heels of a presentation of the company’s latest technology by SensoDetect to psychiatrists from St. Joseph’s Health Care London (St. Joseph’s).
The SensoDetect BERA (Brainstem Evoked Response Audiometry) system uses clicking sounds mixed with noise to measure brain waves.
The resulting data may prove useful in confirming diagnosis of psychiatric conditions including Schizophrenia and Attention Deficit Hyperactive Disorder.
SensoDetect identified London as the premier location for North American testing and validation of their technology. Johan Kallstrand, Chief Executive Officer spoke on behalf of SensoDetect. He said, "We've been pleased with the keen interest and capabilities shown to us by both the academic and business communities in London.
We believe this offers the perfect environment for establishment of North American operations." Studies and testing of the new technology are currently underway in Europe and the company is looking to establish parallel research and validation for the technology in the NAFTA marketplace.
Mayor Fontana welcomed SensoDetect on behalf of the city. The Mayor acknowledged those who have worked together to introduce the Swedish company to London and the opportunity it offers.
He said, “Our city continues to be regarded as a world leader in progressive and innovative health care, life science and the medical device sector.
LHSC’s - CSTAR has again used its global reputation to bring together and integrate the resources in London’s research community and specialized disciplines. The resulting partnerships will serve to benefit mental health patients here and around the world. Congratulations to all involved.”
"Our organization is committed to focusing on innovation and research that will help us to provide the best care in mental health. What better way than to investigate technologies like SensoDetect BERA which could potentially lead to better treatment plans and more positive outcomes for patients," added Dr. Gillian Kernaghan, President and CEO of St. Joseph's.
When the SensoDetect BERA system clicking sounds reach the ear of the patient through headphones, they are converted into electric signals by the hair cells. These signals are then processed as they move along the auditory pathway to the brain. Signals are measured by electrodes placed on the patients head. Because individuals in certain psychiatric or neuropsychiatric diagnostic groups show different brain activity than other groups when hearing the click sounds test results can be compared.
